tiprankstipranks
Trending News
More News >
MKSystem Corp. (JP:3910)
:3910
Japanese Market
Advertisement

MKSystem Corp. (3910) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3910

MKSystem Corp.

(3910)

Rating:45Neutral
Price Target:
¥302.00
▼(-2.27%Downside)
The overall score reflects significant financial performance challenges, including negative profitability and liquidity concerns. Technical indicators suggest bearish market sentiment. Although the company has some balance sheet stability, the valuation remains unattractive due to ongoing financial struggles.

MKSystem Corp. (3910) vs. iShares MSCI Japan ETF (EWJ)

MKSystem Corp. Business Overview & Revenue Model

Company DescriptionMKSystem Corp. (3910) is a technology company specializing in the development and provision of software solutions and services. The company operates primarily in the information technology sector, offering a range of products that cater to enterprise management needs. Its core offerings include software platforms for human resource management, payroll, and other administrative functions, designed to enhance operational efficiency for its clients.
How the Company Makes MoneyMKSystem Corp. generates revenue through the sale and licensing of its software products and solutions to businesses. The company employs a subscription-based model for its software services, providing regular updates and support as part of the package. Additionally, MKSystem may offer consulting and customization services to tailor its software solutions to the specific needs of its clients, thereby generating additional revenue. Key partnerships with other technology firms and integration with third-party platforms could also play a significant role in expanding its market reach and enhancing its service offerings.

MKSystem Corp. Financial Statement Overview

Summary
MKSystem Corp. faces challenges in profitability with a negative net profit margin and fluctuating revenue, despite having some balance sheet stability through equity financing. The negative cash flow to net income ratio suggests potential liquidity issues. Overall, the company needs strategic adjustments to improve its financial health.
Income Statement
45
Neutral
MKSystem Corp. has faced declining revenue since 2023, with a significant net loss reported in 2025. The gross profit margin stands at approximately 38.4%, but the net profit margin is negative due to consistent net losses. The revenue growth over the past periods shows a fluctuating pattern, indicating instability in revenue generation.
Balance Sheet
55
Neutral
The company has a relatively high debt-to-equity ratio of approximately 1.80 in 2025, reflecting a leveraged position. Stockholders' equity has decreased slightly, impacting the equity ratio, which is around 27.3% for 2025. Despite the financial leverage, the company's assets are primarily financed through equity, showcasing some stability.
Cash Flow
40
Negative
Operating cash flow improved in 2025 but remains lower than net income, demonstrating operational challenges. Free cash flow has turned positive, but the free cash flow to net income ratio indicates inefficiency in converting net income into cash. The cash flow situation suggests potential liquidity issues.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue3.29B2.64B2.87B2.74B2.44B
Gross Profit1.26B858.20M1.35B1.27B1.20B
EBITDA324.66M-216.03M621.97M547.27M582.03M
Net Income-118.57M-668.52M145.58M91.39M138.05M
Balance Sheet
Total Assets2.44B2.56B2.56B2.23B2.24B
Cash, Cash Equivalents and Short-Term Investments606.32M711.78M609.34M468.15M644.49M
Total Debt1.20B1.33B510.59M378.85M486.15M
Total Liabilities1.77B1.74B1.03B807.30M839.54M
Stockholders Equity667.43M807.71M1.52B1.42B1.36B
Cash Flow
Free Cash Flow263.80M-675.95M53.88M2.80M-60.47M
Operating Cash Flow276.07M-316.74M617.25M493.73M340.18M
Investing Cash Flow-234.14M-353.44M-557.42M-472.47M-381.12M
Financing Cash Flow-147.38M772.62M88.45M-177.55M-64.54M

MKSystem Corp. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price309.00
Price Trends
50DMA
319.04
Negative
100DMA
313.97
Negative
200DMA
309.68
Negative
Market Momentum
MACD
-2.49
Positive
RSI
41.47
Neutral
STOCH
61.44
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3910, the sentiment is Negative. The current price of 309 is below the 20-day moving average (MA) of 316.75, below the 50-day MA of 319.04, and below the 200-day MA of 309.68, indicating a bearish trend. The MACD of -2.49 indicates Positive momentum. The RSI at 41.47 is Neutral, neither overbought nor oversold. The STOCH value of 61.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3910.

MKSystem Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
¥3.07B36.67
-0.88%
63
Neutral
$34.70B4.89-11.39%1.66%5.53%-19.00%
52
Neutral
¥1.69B86.66
17.30%
51
Neutral
¥1.93B
-20.17%-455.68%
50
Neutral
¥2.08B
-11.56%50.90%
45
Neutral
¥1.69B
1.28%24.63%82.26%
35
Underperform
¥1.82B
-5.40%-18.52%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3910
MKSystem Corp.
312.00
-37.59
-10.75%
JP:3913
GreenBee. Inc.
1,251.00
546.00
77.45%
JP:4166
Cacco, Inc.
762.00
-1.00
-0.13%
JP:4179
G-NEXT, Inc.
337.00
51.00
17.83%
JP:4255
THECOO Inc.
799.00
299.00
59.80%
JP:4424
Amazia, Inc.
293.00
-221.00
-43.00%

MKSystem Corp. Corporate Events

MKSystem Corp. Reports Improved Sales Amidst Continued Losses
May 21, 2025

MKSystem Corporation reported a significant improvement in its financial performance for the fiscal year ending March 31, 2025, with net sales increasing by 24.6% compared to the previous year. Despite the increase in sales, the company still faced challenges with a net loss, but it showed a positive cash flow from operating activities, indicating potential recovery and improved financial health.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 11, 2025